- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 57.74% based on similar historical setup states.
FF
MIL
Week ended 07 Aug 2026
Weekly Investor Report
Fine Foods & Pharmaceuticals N.T.M. S.p.A. · Consumer Defensive · Packaged Foods
Latest close
8.22 EUR
-1.2%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -10.1% below the Trend Line and sits at 10.7% of its 52-week range. The latest completed week returned -1.2%, after a -8.1% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.
Setup score
31
out of 100
Latest Close
8.22 EUR
7 Aug 2026
1W Return
-1.2%
latest completed week
4W Return
-8.1%
short-term follow-through
12W Return
1.2%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.2%
Latest completed week; four-week move -8.1%.
Indicator stack
34/26
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 57.74%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
12 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.1% below the Trend Line and sits at 10.7% of its 52-week range. The latest completed week returned -1.2%, after a -8.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1212-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.1% over four weeks, 1.2% over 12 weeks, and -1.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.27Latest activity-pressure read.
Pressure change-236.4%Four-week change in activity pressure.
Leadership-22.63Latest relative-leadership reading.
RS change-48.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 12 relevant articles.
1 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.7%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+10.6%Week of 17 Apr.
Worst week-19.8%Week of 13 Mar.
Latest week-1.2%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses6
Sharp losses5
Recent vol3.8%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIT Consumer Defensive
4-week rank17 / 19
Group average-0.7%
Trend breadth21.1%
Trend21.1%active weekly trend signals
MD52.6%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
IndustryIT Packaged Foods
4-week rank6 / 7
Group average-0.1%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD71.4%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.12; No reversal markers Next-Week ExpectancyPositive 57.74%Next-week expectancy is positive with a 57.74% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 12 relevant articles.
Fine Foods & Pharmaceuticals N.T.M. SpA Revenue Breakdown – MIL:FF Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 8.22 EUR | -1.2% | 9.14 EUR | 8.19 EUR | -0.27 | -22.63 | 100.3K | Off |
| 31 Jul 2026 | 8.32 EUR | 1.0% | 9.17 EUR | 8.19 EUR | -0.04 | -19.74 | 131.5K | Off |
| 24 Jul 2026 | 8.24 EUR | -7.0% | 9.21 EUR | 8.18 EUR | 0.14 | -20.16 | 136.2K | Off |
| 17 Jul 2026 | 8.86 EUR | -0.9% | 9.24 EUR | 8.18 EUR | 0.28 | -14.56 | 164.4K | Off |
| 10 Jul 2026 | 8.94 EUR | -1.5% | 9.26 EUR | 8.17 EUR | 0.20 | -15.20 | 230.6K | Off |
| 3 Jul 2026 | 9.08 EUR | 2.5% | 9.29 EUR | 8.16 EUR | -0.07 | -14.41 | 131.6K | Off |
| 26 Jun 2026 | 8.86 EUR | 0.7% | 9.29 EUR | 8.15 EUR | -0.40 | -14.14 | 36.4K | Off |
| 19 Jun 2026 | 8.80 EUR | -1.6% | 9.31 EUR | 8.14 EUR | -0.62 | -17.48 | 47.6K | Off |
| 12 Jun 2026 | 8.94 EUR | 4.0% | 9.31 EUR | 8.14 EUR | -0.81 | -14.24 | 39.6K | Off |
| 5 Jun 2026 | 8.60 EUR | -5.7% | 9.32 EUR | 8.13 EUR | -0.89 | -14.97 | 34.5K | Off |
| 29 May 2026 | 9.12 EUR | 5.3% | 9.33 EUR | 8.13 EUR | -0.83 | -10.14 | 161.2K | Off |
| 22 May 2026 | 8.66 EUR | 6.7% | 9.33 EUR | 8.12 EUR | -0.85 | -13.76 | 221.5K | Off |
| 15 May 2026 | 8.12 EUR | 0.7% | 9.35 EUR | 8.11 EUR | -0.86 | -18.53 | 361.3K | Off |
| 8 May 2026 | 8.06 EUR | -12.8% | 9.37 EUR | 8.11 EUR | -0.78 | -19.57 | 442.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.